_PRIVATE_LIMITED.webp)
Jainson Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 1.00 M
as on 05-07-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.02 M
as on 05-07-2024
- Revenue 7.09%
(FY 2023)
- Profit 299.21%
(FY 2023)
- Ebitda 77.77%
(FY 2023)
- Net Worth 4.87%
(FY 2023)
- Total Assets -6.53%
(FY 2023)
About Jainson Biotech (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.02 M.
Praveen Jain, Meera Gupta, Ritu Jain, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233UP2009PTC037468
- Company No.
037468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Jainson Biotech (India)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Jain  | Director | 28-May-2009 | Current |
| Meera Gupta | Director | 28-May-2009 | Current |
| Ritu Jain | Director | 28-May-2009 | Current |
| Ram Gupta | Director | 28-May-2009 | Current |
Financial Performance of Jainson Biotech (India).
Jainson Biotech (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.09% increase. The company also saw a substantial improvement in profitability, with a 299.21% increase in profit. The company's net worth moved up by a moderate rise of 4.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jainson Biotech (India)?
In 2023, Jainson Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Aug 2023 | ₹2.02 M | Open |
How Many Employees Work at Jainson Biotech (India)?
Unlock and access historical data on people associated with Jainson Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jainson Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jainson Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
